Physician profile
Sarina Sachdev
NPI 1972916278
$5,853.43
in general payments reported to CMS, 2019-2025
34 companies · $1,241 in 2025
The $1,241 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $614 · 2021: $811 · 2022: $267 · 2023: $980 · 2024: $1,563 · 2025: $1,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,784.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,462.56 | 2021-2025 | Impella |
| Medtronic, INC. | $660.14 | 2021-2025 | Hawkone, Corevalve Evolut R, Symplicity G3 |
| Bard Peripheral Vascular, INC. | $496.61 | 2023-2025 | Crosser Iq, Crosser Iq |
| Abbott Laboratories | $436.76 | 2019-2023 | Jot Dx |
| Boston Scientific Corporation | $365.55 | 2019-2021 | |
| Angiodynamics, INC. | $274.55 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $270.15 | 2022-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $250.53 | 2020-2023 | Lifevest |
| Inari Medical, INC. | $186.66 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $166.54 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Corcept Therapeutics | $143.32 | 2025 | Korlym |
| Amgen INC. | $134.24 | 2019-2020 | |
| Penumbra, INC. | $125.73 | 2025 | Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.73 | 2020 | |
| Pfizer INC. | $90.64 | 2019-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $82.84 | 2024 | |
| Cordis US Corp. | $75.00 | 2023 | Mynx Control |
| Cardiovascular Systems INC. | $70.61 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $58.49 | 2019-2024 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $56.12 | 2019-2025 | Farxiga |
| Cleerly, INC. | $46.79 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Alnylam Pharmaceuticals INC. | $46.49 | 2019 | |
| Tactile Systems Technology INC | $37.82 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Cardinal Health 200 LLC | $33.05 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $21.50 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.59 | 2025 | |
| Novartis Pharmaceuticals Corporation | $19.58 | 2024 | |
| Sanofi-Aventis U.S. LLC | $19.02 | 2019 | |
| Convatec INC. | $17.60 | 2024 | |
| Cook Medical LLC | $17.32 | 2023 | Zilver Vena |
| Kiniksa Pharmaceuticals, LTD. | $17.00 | 2023 | Arcalyst |
| Novo Nordisk INC | $15.58 | 2019 | |
| Lantheus Medical Imaging, INC. | $14.95 | 2020 | |
| Medtronic Vascular, INC. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarina Sachdev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.